In short
Cilostazol is a medication that has been studied for various medical conditions across multiple clinical trials. As a phosphodiesterase type 3 (PDE3) inhibitor, it works by preventing the breakdown of cyclic adenosine monophosphate (cAMP), which leads to vasodilation (widening of blood vessels) and inhibition of platelet aggregation (preventing blood clots). This article examines how cilostazol has been investigated in clinical trials for different conditions, from cardiovascular diseases to reproductive health and neurological disorders. Understanding these research efforts can provide valuable insights into the potential therapeutic applications of this medication.
Key points
- Cilostazol, a phosphodiesterase type 3 inhibitor, has been investigated in multiple clinical trials across various medical conditions. Its ability to dilate blood vessels and prevent platelet clumping makes it valuable for vascular conditions like peripheral artery disease, stroke prevention, and carotid artery stenosis. Research has also explored unexpected applications including potential use as a non-hormonal contraceptive by preventing egg maturation, treatment for tinnitus through improved cochlear blood flow, and benefits in Alzheimer's disease patients with white matter changes. Most trials administer cilostazol at doses of 100-200mg daily, comparing it with placebo or established treatments like aspirin or clopidogrel. These diverse applications highlight cilostazol's versatility as a therapeutic agent beyond its established uses.
What is Cilostazol?
Cilostazol is a medication primarily used to treat the symptoms of intermittent claudication, which is a type of leg pain caused by poor blood circulation during walking or exercise. It belongs to a class of drugs known as phosphodiesterase inhibitors. The drug is marketed under various brand names including Pletal and Pletaal.
Cilostazol works by improving blood flow in the legs and reducing blood clotting. It helps widen blood vessels and prevents platelets (a type of blood cell) from sticking together and forming clots.
How Does Cilostazol Work?
Cilostazol is a selective inhibitor of phosphodiesterase type 3 (PDE3). This enzyme normally breaks down cyclic adenosine monophosphate (cAMP), an important cellular signaling molecule. By inhibiting PDE3, cilostazol increases the amount of cAMP in blood vessels and platelets.
The increased cAMP levels result in several important effects:
- Vasodilation: Cilostazol causes blood vessels to widen, which improves blood flow.
- Inhibition of platelet aggregation: The drug prevents platelets from clumping together, reducing the risk of blood clots.
- Improvement in blood lipid levels: Cilostazol can decrease triglyceride levels and increase HDL (good) cholesterol levels.
Medical Uses
Cilostazol has been approved and studied for various medical conditions, primarily related to blood vessel and circulation problems:
Peripheral Artery Disease and Intermittent Claudication
The primary FDA-approved use of cilostazol is for the treatment of intermittent claudication symptoms in people with peripheral arterial disease (PAD). PAD is a condition where narrowed arteries reduce blood flow to the limbs, usually the legs.
Intermittent claudication causes pain, cramping, or aching in the calves, thighs, or buttocks during walking or exercise, which typically subsides with rest. Cilostazol helps to increase walking distance and reduce claudication symptoms in these patients.
Research has shown that cilostazol is also effective in preventing restenosis (re-narrowing of blood vessels) after endovascular procedures such as angioplasty or stent placement in peripheral arteries. Several studies conducted in Japan demonstrated that cilostazol improves patency (openness) of treated blood vessels following these interventions.
Stroke Prevention and Treatment
Cilostazol has shown promising results in preventing the recurrence of cerebral infarction (ischemic stroke). In the Cilostazol Stroke Prevention Study, a double-blind, placebo-controlled trial, cilostazol was assessed for its long-term safety and efficacy in preventing the recurrence of cerebral infarction in patients who had suffered a stroke 1 to 6 months prior to entering the trial.
Studies have also examined cilostazol's effectiveness in treating symptomatic intracranial arterial stenosis (narrowing of arteries inside the brain), which is a major cause of stroke. Research has compared cilostazol to other antiplatelet medications like clopidogrel for preventing the progression of this condition.
Additionally, cilostazol has been studied for use in acute minor stroke and transient ischemic attack (TIA), comparing its effectiveness when combined with aspirin versus other antiplatelet combinations.
Heart and Blood Vessel Conditions
Cilostazol has been investigated for its effects on various heart and blood vessel conditions:
- Carotid artery stenting: Research suggests that cilostazol may reduce in-stent restenosis following carotid artery stenting procedures, which are performed to open narrowed carotid arteries (the main blood vessels that supply blood to the brain).
- Coronary artery disease: Studies have examined cilostazol's effects when added to standard antiplatelet therapy after drug-eluting stent implantation in coronary arteries.
- Vasospastic angina: Cilostazol has been studied for treating vasospastic angina, a type of chest pain caused by spasm of the coronary arteries.
Potential Emerging Uses
Ongoing research is exploring several other potential uses for cilostazol:
- Diabetic polyneuropathy: Some studies are investigating cilostazol's effectiveness in treating nerve damage caused by diabetes.
- Tinnitus: Research has examined whether cilostazol can improve chronic tinnitus (ringing in the ears) by enhancing blood flow to the inner ear.
- Raynaud's phenomenon: Cilostazol has been studied for treating Raynaud's phenomenon, a condition where blood vessels in the fingers and toes spasm in response to cold or stress.
- Alzheimer's disease: Some research is exploring cilostazol's potential for treating Alzheimer's disease, particularly in patients with subcortical white matter hyperintensities (areas of damage in the brain's white matter).
- Cerebral small vessel disease: Studies are investigating whether cilostazol can slow the progression of cerebral small vessel disease, which increases the risk of stroke and dementia.
- Contraception: Interestingly, cilostazol has been studied for its potential as a non-hormonal contraceptive method. Research has explored its effects on human oocyte (egg cell) maturation.
Dosage and Administration
Cilostazol is typically taken orally in tablet form. The standard dosage for adults is usually 100 mg twice daily, taken at least 30 minutes before or 2 hours after breakfast and dinner. This timing is important because food, especially high-fat meals, can increase the absorption of cilostazol.
For some patients, particularly those taking medications that may interact with cilostazol or those with certain health conditions, a lower dose of 50 mg twice daily may be recommended.
It's important to note that the full beneficial effects of cilostazol may take 2-4 weeks or longer to become noticeable.
Side Effects
Common side effects of cilostazol may include:
- Headache
- Diarrhea
- Abnormal stools
- Increased heart rate (tachycardia)
- Palpitations
- Dizziness
- Nausea
Most of these side effects are mild to moderate and often improve as your body adjusts to the medication.
More serious but less common side effects may include:
- Significant drop in blood pressure
- Bleeding complications
- Heart rhythm abnormalities
- Severe headaches
Cilostazol should not be used in patients with heart failure, as PDE3 inhibitors have been associated with increased mortality in these patients.
Drug Interactions
Cilostazol may interact with various medications, including:
- Other antiplatelet drugs or anticoagulants: Combining cilostazol with aspirin, clopidogrel, or blood thinners may increase the risk of bleeding.
- CYP3A4 and CYP2C19 inhibitors: Medications that inhibit these liver enzymes can increase cilostazol levels in the blood. These include certain antibiotics, antifungals, and grapefruit juice.
- Statins: Some interactions with cholesterol-lowering medications have been reported.
Always inform your healthcare provider about all medications, supplements, and herbal products you are taking before starting cilostazol.
Special Populations
Elderly Patients
Older adults may be more sensitive to the side effects of cilostazol, particularly dizziness or heart-related effects. Careful monitoring may be needed.
Patients with Kidney or Liver Problems
Dosage adjustments may be necessary for patients with kidney or liver impairment, as these conditions can affect how the body processes cilostazol.
Pregnant or Breastfeeding Women
The safety of cilostazol during pregnancy and breastfeeding has not been well established. Animal studies have shown some potential risks. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the potential risks and benefits with their healthcare provider.
Ongoing Research
Several clinical trials are currently underway to explore additional uses and effects of cilostazol:
- Comparing cilostazol to clopidogrel in type 2 diabetes patients with carotid atherosclerosis.
- Evaluating cilostazol's effect on wound healing in diabetic foot ulcer patients.
- Assessing cilostazol versus aspirin in acute non-cardioembolic stroke patients with cerebral microbleeds.
- Investigating cilostazol's potential for preventing dementia compared to other medications.
These ongoing studies may expand our understanding of cilostazol's therapeutic potential and lead to new approved uses in the future.